Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial

Overview of attention for article published in New England Journal of Medicine, April 2026

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 28 news outlets
blogs: 6 blogs
twitter: 61 X users

facebook: 1 Facebook page
bluesky: 7 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 10 Bluesky posts from 7 Bluesky users, with an upper bound of 37,713 followers.

New in the June 18, 2026, issue of NEJM: Endovascular Therapy for Post-Thrombotic Syndrome (phase 3 C-TRACT trial) nej.md/3QsqxJ2 Prehospital Whole Blood in Traumatic Hemorrhage (phase 3 SWiFT trial) nej.md/4ozfB9Q

"Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial." Publié ce jour dans le @nejm.org. #MedSky www.nejm.org/doi/full/10....

Post-thrombotic syndrome affects quality of life for many DVT patients. The C-TRACT trial found endovascular therapy significantly reduced severity & improved quality of life vs. standard care alone. @ucsfimaging.bsky.social recently presented at #SIR26…

New England Journal of Medicine, Ahead of Print. https://www.nejm.org/doi/full/10.1056/NEJMoa2519001?af=R&rss=currentIssue

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 6 additional Bluesky posts.